Eric J. Ende
Director · AVADEL PHARMACEUTICALS PLC
- 2025
- Feb 12, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Eric J. Ende files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Weiss Asset Management LP - $233.35M in AVDL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Eric J. Ende?
Eric J. Ende is a corporate insider, tracked as Director of AVADEL PHARMACEUTICALS PLC (AVDL). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Eric J. Ende last file a Form 4?
The most recent primary Form 4 on record is dated 12 February 2026, one of 2 filings going back to 2025.